Pharmacology at Penn State College of Medicine
The Department of Pharmacology will provide high quality training of the next generation of scientists and physicians and develop new diagnostic tests, medicines and delivery systems.
The Department of Pharmacology at Penn State College of Medicine is committed to teaching and research in the biomedical sciences. The department occupies 20,000 square of new laboratory space (all built since 2007) in the Hershey Center for Applied Research, Penn State Cancer Institute and Penn State Institute for Personalized Medicine. Research ranges from cell and molecular studies of cancer to biochemical/ pharmacological investigation of nervous system function (neurodegenerative disease, cognition and substance abuse) to whole animal studies of drug development.
Educationally, the department is involved in medical, graduate and allied health instruction and training. Former PhD trainees of the department are currently employed as professors, entrepreneurs, research scientists and administrators throughout the world. Our faculty serve as educational leaders within the university and across the nation. We are assistant deans, course directors, textbook authors and PhD program directors.
This is an exciting time in biomedical research and teaching. Join us for graduate school, for a postdoctoral position, as a faculty member. We are... Penn State Pharmacology.
Kent Vrana, PhD
Pharmacology Department Chair
Penn State College of Medicine
More about Pharmacology @ Penn State
Latest from Pharmacology
- Resume and CV reviews for graduate students
Jan 27, 2020 11:30 AM ESTRoom C3700 – Penn State College of Medicine
- IRB Board C Review Meeting
Jan 27, 2020 1:00 PM ESTRoom T2500 – Penn State Cancer Institute
- Neuroscience Student Seminar: Emily Blanke
Jan 28, 2020 12:00 PM ESTRoom C3700 – Penn State College of Medicine
- Biomedical Sciences Seminar Series: Michelle Green and Eric Yau
Jan 28, 2020 4:00 PM ESTLecture Room C (Room C6616) – Penn State College of Medicine
- Commission for Women: “Color Blind or Color Brave?”
Jan 29, 2020 12:00 PM ESTLecture Room A (Room C4618) – Penn State College of Medicine
- Biostatistics seminar: “A Bayesian Statistical Framework for Microbiome Sequence Data Analysis”
Jan 30, 2020 12:00 PM ESTAcademic Support Building (ASB) Room 2200G
- Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.Kim S, Zhang Y, Tang S, Qin C, Karelia D, Sharma A, Jiang C, Lu J. Prostate 2019 Jun;79(9):949-960
- The novel Isatin analog KS99 targets stemness markers in acute myeloid leukemia.Annageldiyev C, Gowda K, Patel T, Bhattacharya P, Tan SF, Iyer S, Desai D, Dovat S, Feith DJ, Loughran TP Jr, Amin S, Claxton D, Sharma A. Haematologica 2019 May 23. pii: haematol.2018.212886 [Epub ahead of print]
- Targeting IDH1 as a pro-senescent therapy in high-grade serous ovarian cancer.Dahl ES, Buj R, Leon KE, Newell JM, Imamura Y, Bitler BG, Snyder NW, Aird KM. Mol Cancer Res 2019 May 20. pii: molcanres.1233.2018 [Epub ahead of print]
- Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity.Ding Y, Zhang B, Payne JL, Song C, Ge Z, Gowda C, Iyer S, Dhanyamraju PK, Dorsam G, Reeves ME, Desai D, Huang S, Payne KJ, Yue F, Dovat S. Leukemia 2019 May 9 [Epub ahead of print]